QIAGEN NV (QGEN)
44.97
-0.35
(-0.77%)
USD |
NYSE |
Dec 31, 16:00
44.96
-0.01
(-0.02%)
After-Hours: 20:00
QIAGEN Market Cap: 9.751B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InflaRx NV | 68.42M |
| CDT Equity, Inc. | 2.086M |
| LENZ Therapeutics, Inc. | 500.64M |
| Liminatus Pharma, Inc. | 16.51M |
| Oruka Therapeutics, Inc. | 1.467B |
Market Cap Related Metrics
| PE Ratio | 24.26 |
| PS Ratio | 4.750 |
| PEG Ratio | 0.0676 |
| Price to Book Value | 2.672 |
| Price to Free Cash Flow | 20.82 |
| Price | 44.97 |
| Earnings Yield | 4.12% |
| PEGY Ratio | 0.0669 |
| Operating PE Ratio | 18.07 |
| Normalized PE Ratio | 21.82 |